Newborn screening for Duchenne muscular dystrophy: the perspectives of stakeholders
-
Published:2024-04
Issue:
Volume:45
Page:101049
-
ISSN:2666-6065
-
Container-title:The Lancet Regional Health - Western Pacific
-
language:en
-
Short-container-title:The Lancet Regional Health - Western Pacific
Author:
Ji Charli,
Kariyawasam Didu S.,
Sampaio Hugo,
Lorentzos Michelle,
Jones Kristi J.,
Farrar Michelle A.ORCID
Reference41 articles.
1. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis;Crisafulli;Orphanet J Rare Dis,2020
2. Therapeutic developments for Duchenne muscular dystrophy;Verhaart;Nat Rev Neurol,2019
3. Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis;Landfeldt;Eur J Epidemiol,2020
4. Age, corticosteroid treatment and site of mutations affect motor functional changes in young boys with Duchenne muscular dystrophy;Coratti;PLoS One,2022
5. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management;Birnkrant;Lancet Neurol,2018